Sirio Pharma Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Sirio Pharma stock have an average target of ¥25.00, which predicts a 48.46% increase from the current stock price of 16.84.

Price Target: ¥25.00 (+48.46%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	¥25.00	¥25.00	¥25.00	¥25.00
Change	+48.46%	+48.46%	+48.46%	+48.46%

Analyst Ratings

The average analyst rating for Sirio Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Jan '26	Feb '26	Apr '26	May '26	Jun '26
Strong Buy	3	3	4	3	2	1
Buy	1	2	1	1	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	5	5	4	4	3

Financial Forecast

Revenue This Year

4.67B

from 4.26B

9.60%

from 4.26B

Revenue Next Year

5.40B

from 4.67B

15.58%

from 4.67B

EPS This Year

1.65

from 0.24

585.90%

from 0.24

EPS Next Year

n/a

from 1.65

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Jan 1, 2023	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	2.37B	2.51B	3.58B	4.21B	4.26B	4.67B
Revenue Growth	14.62%	5.84%	42.87%	17.56%	1.23%	9.60%
Gross Profit	764.94M	770.42M	1.08B	1.32B	1.22B	1.49B
Gross Margin	32.29%	30.73%	30.28%	31.34%	28.62%	31.83%
Operating Income	281.11M	242.59M	376.33M	396.78M	209.97M	401.00M
Net Income	231.83M	212.29M	281.04M	325.06M	136.53M	375.00M
EPS	-	-	-	-	0.24	1.65
EPS Growth	-	-	-	-	-77.76%	585.90%
Forward PE	-	-	19.62	15.13	18.70	10.23
Dividend / Share	0.24	0.21	0.65	0.50	0.13	0.45
Dividend Growth	-	-12.51%	214.29%	-23.18%	-74.00%	246.15%
Free Cash Flow	-289.58M	24.38M	-211.19M	16.37M	110.30M	316.00M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue	2026	2027	2028
High	4.7B
Avg	4.7B
Low	4.7B

Revenue Growth

Revenue Growth	2026	2027	2028
High	10.0%
Avg	9.6%
Low	9.2%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	1.65
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	585.9%
Low	-